Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

Emily Adland^#¹, Jane Millar^#^{1

2}, Nomonde Bengu³, Maximilian Muenchhoff^{4

5}, Rowena Fillis³, Kenneth Sprenger³, Vuyokasi Ntlantsana⁶, Julia Roider^{5

7}, Vinicius Vieira¹, Katya Govender⁸, John Adamson⁸, Nelisiwe Nxele², Christina Ochsenbauer⁹, John Kappes^{9

10}, Luisa Mori¹, Jeroen van Lobenstein¹¹, Yeney Graza¹², Kogielambal Chinniah¹³, Constant Kapongo¹⁴, Roopesh Bhoola¹⁵, Malini Krishna¹⁵, Philippa C Matthews¹⁶, Ruth Penya Poderos¹⁷, Marta Colomer Lluch¹⁷, Maria C Puertas¹⁷, Julia G Prado¹⁷, Neil McKerrow¹², Moherndran Archary¹⁸, Thumbi Ndung'u^{2

8

19}, Andreas Groll²⁰, Pieter Jooste²¹, Javier Martinez-Picado^{17

22

23}, Marcus Altfeld²⁴, Philip Goulder^{25

26

27

28}

Affiliations

¹ Department of Paediatrics, University of Oxford, Oxford, UK.
² HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
³ Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
⁴ Max von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany.
⁵ German Center for Infection Research (DZIF), Partner site Munich, Munich, Germany.
⁶ Department of Medicine, University of KwaZulu-Natal, Durban, South Africa.
⁷ Department of Infectious Diseases, Ludwig-Maximilians-University, Munich, Germany.
⁸ Africa Health Research Institute, Durban, South Africa.
⁹ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, 35233, USA.
¹¹ Stanger Hospital, KwaDukuza, KwaZulu-Natal, South Africa.
¹² KwaZulu-Natal Department of Health, Pietermartizburg, South Africa.
¹³ Mahatma Gandhi Memorial Hospital, Phoenix, KwaZulu-Natal, South Africa.
¹⁴ Queen Nandi Regional Hospital, Empangeni, KwaZulu-Natal, South Africa.
¹⁵ Edendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.
¹⁶ Nuffield Department of Medicine, University of Oxford, Oxford, UK.
¹⁷ IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
¹⁸ Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa.
¹⁹ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
²⁰ TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.
²¹ Department of Paediatrics, Kimberley Hospital, Northern Cape, South Africa.
²² University of Vic-Central University of Catalonia (UVic-UCC), Catalonia, Spain.
²³ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
²⁴ Virus Immunology Unit, Heinrich-Pette-Institut, Hamburg, Germany.
²⁵ Department of Paediatrics, University of Oxford, Oxford, UK. philip.goulder@paediatrics.ox.ac.uk.
²⁶ HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
²⁷ Africa Health Research Institute, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
²⁸ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA. philip.goulder@paediatrics.ox.ac.uk.

^# Contributed equally.

PMID: 32367015
PMCID: PMC7198495
DOI: 10.1038/s41467-020-16215-7

Published Erratum

Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

Emily Adland et al. Nat Commun. 2020.

. 2020 May 4;11(1):2257.

doi: 10.1038/s41467-020-16215-7.

Authors

Affiliations

¹ Department of Paediatrics, University of Oxford, Oxford, UK.
² HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
³ Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
⁴ Max von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany.
⁵ German Center for Infection Research (DZIF), Partner site Munich, Munich, Germany.
⁶ Department of Medicine, University of KwaZulu-Natal, Durban, South Africa.
⁷ Department of Infectious Diseases, Ludwig-Maximilians-University, Munich, Germany.
⁸ Africa Health Research Institute, Durban, South Africa.
⁹ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, 35233, USA.
¹¹ Stanger Hospital, KwaDukuza, KwaZulu-Natal, South Africa.
¹² KwaZulu-Natal Department of Health, Pietermartizburg, South Africa.
¹³ Mahatma Gandhi Memorial Hospital, Phoenix, KwaZulu-Natal, South Africa.
¹⁴ Queen Nandi Regional Hospital, Empangeni, KwaZulu-Natal, South Africa.
¹⁵ Edendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.
¹⁶ Nuffield Department of Medicine, University of Oxford, Oxford, UK.
¹⁷ IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
¹⁸ Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa.
¹⁹ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
²⁰ TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.
²¹ Department of Paediatrics, Kimberley Hospital, Northern Cape, South Africa.
²² University of Vic-Central University of Catalonia (UVic-UCC), Catalonia, Spain.
²³ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
²⁴ Virus Immunology Unit, Heinrich-Pette-Institut, Hamburg, Germany.
²⁵ Department of Paediatrics, University of Oxford, Oxford, UK. philip.goulder@paediatrics.ox.ac.uk.
²⁶ HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
²⁷ Africa Health Research Institute, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
²⁸ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA. philip.goulder@paediatrics.ox.ac.uk.

^# Contributed equally.

PMID: 32367015
PMCID: PMC7198495
DOI: 10.1038/s41467-020-16215-7

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.
Adland E, Millar J, Bengu N, Muenchhoff M, Fillis R, Sprenger K, Ntlantsana V, Roider J, Vieira V, Govender K, Adamson J, Nxele N, Ochsenbauer C, Kappes J, Mori L, van Lobenstein J, Graza Y, Chinniah K, Kapongo C, Bhoola R, Krishna M, Matthews PC, Poderos RP, Lluch MC, Puertas MC, Prado JG, McKerrow N, Archary M, Ndung'u T, Groll A, Jooste P, Martinez-Picado J, Altfeld M, Goulder P. Adland E, et al. Nat Commun. 2020 Apr 14;11(1):1767. doi: 10.1038/s41467-020-15632-y. Nat Commun. 2020. PMID: 32286302 Free PMC article.

Publication types

Actions

Grants and funding

R01 AI133673/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

Affiliations

Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources